Corcept Therapeutics, Inc. (CORT)
87.99
+0.86
(+0.99%)
USD |
NASDAQ |
Dec 12, 16:00
88.35
+0.36
(+0.41%)
After-Hours: 05:08
Corcept Therapeutics Research and Development Expense (Annual): 246.89M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 5.676B |
| Gilead Sciences, Inc. | 5.816B |
| United Therapeutics Corp. | 481.00M |
| Vertex Pharmaceuticals, Inc. | 3.630B |
| Theravance Biopharma, Inc. | 36.04M |